» Articles » PMID: 38757052

Successful Extension of Vascularized Composite Allograft Perfusion Cold Storage to 24 H in a Rat Hindlimb Transplant Model

Abstract

Background: Vascularized composite allograft transplantation is a treatment option for complex tissue injuries; however, ischemia reperfusion injury and high acute rejection rates remain a challenge. Hypothermic machine perfusion using acellular storage perfusate is a potential solution. This study evaluated the University of Wisconsin Kidney Preservation Solution-1 (KPS-1) compared with normal saline (NS) for preservation of donor rat hindlimbs subjected to 24 h of ex vivo perfusion cold storage.

Methods: Hindlimbs were subjected to 24-h perfusion cold storage with heparinized KPS-1 (n = 6) or heparinized NS (n = 6). Flow, resistance, and pH were measured continuously. At the end of the 24-h period, tissue was collected for histological analysis of edema and apoptosis.

Results: KPS-1 perfused limbs showed significantly less edema than the NS group, as evidenced by lower limb weight gain ( < 0.001) and less interfascicular space ( < 0.001). KPS-perfused muscle had significantly less cell death than NS-perfused muscle based on terminal deoxynucleotidyl transferase dUTP nick-end labeling ( < 0.001) and cleaved caspase-3 staining ( = 0.045). During hypothermic machine perfusion, a significant decrease in pH over time was detected in both groups, with a significantly greater decline in pH in the KPS-1 group than in the NS group. There were no significant differences overall and over time in flow rate or vascular resistance between the KPS and NS groups.

Conclusions: Perfusion with KPS-1 can successfully extend vascularized composite allograft perfusion cold storage for 24 h in a rat hindlimb model without significant edema or cell death.

References
1.
Gok E, Alghanem F, Moon R, Guy E, Rojas-Pena A, Bartlett R . Development of an Ex-Situ Limb Perfusion System for a Rodent Model. ASAIO J. 2018; 65(2):167-172. PMC: 6158126. DOI: 10.1097/MAT.0000000000000786. View

2.
Conrad A, Petruzzo P, Kanitakis J, Gazarian A, Badet L, Thaunat O . Infections after upper extremity allotransplantation: a worldwide population cohort study, 1998-2017. Transpl Int. 2019; 32(7):693-701. DOI: 10.1111/tri.13399. View

3.
Datta S, Fitzpatrick A, Haykal S . Preservation solutions for attenuation of ischemia-reperfusion injury in vascularized composite allotransplantation. SAGE Open Med. 2021; 9:20503121211034924. PMC: 8312154. DOI: 10.1177/20503121211034924. View

4.
Li H, Sun S, Yap J, Chen J, Qian Q . 0.9% saline is neither normal nor physiological. J Zhejiang Univ Sci B. 2016; 17(3):181-7. PMC: 4794509. DOI: 10.1631/jzus.B1500201. View

5.
Burlage L, Tessier S, Etra J, Uygun K, Brandacher G . Advances in machine perfusion, organ preservation, and cryobiology: potential impact on vascularized composite allotransplantation. Curr Opin Organ Transplant. 2018; 23(5):561-567. PMC: 6449688. DOI: 10.1097/MOT.0000000000000567. View